Data-driven platform selection for automated cell therapy manufacturing

As automated CAR T manufacturing moves toward commercialization, platform selection decisions increasingly depend on objective, comparative data rather than theoretical capabilities.

In this live CGTI webinar, Alex Sargent, PhD from Charles River will present comparative data generated from multiple CAR T manufacturing runs, evaluating our Sefia™ platform against an all in one standard solution under the same conditions and reagents.

The session will explore how this independent data can support confident, data driven automation decisions.

What will be covered:
• How Charles River designed and executed a side by side comparison of Sefia and an all in one standard platform
• Key performance insights generated from multiple CAR T manufacturing runs under identical conditions
• What the data reveals about process consistency, operational flexibility, and scalability considerations
• How comparative data can support platform selection, technology transfer, and future commercialization planning